Cost Effectiveness Analysis Applied to the Treatment of Chronic Renal Disease

  title={Cost Effectiveness Analysis Applied to the Treatment of Chronic Renal Disease},
  author={Herbert E. Klarman and Jhon O S. Francis and Gerald D. Rosenthal},
  journal={Medical Care},
Cost Effectiveness Analysis Applied to the Treatment of Chronic Renal Disease Herbert Klarman;John Francis;Gerald Rosenthal; Medical Care 

Cost-Effectiveness Analysis

Cost-effectiveness analysis is a fundamental aspect of the evaluation of health care interventions; however, it remains poorly understood by clinicians. This makes the interpretation and assessment

[Cost-effectiveness analysis of renal replacement therapies: how should we design research on these interventions in Brazil?].

A review was conducted on the interventions and their alternative courses from the perspective of the various methodological proposals in the literature, considering the availability of data and information in Brazil to back this type of research.

Benefit and cost analysis in geriatric care. Turning age discrimination into health policy.

  • J. Avorn
  • Medicine, Political Science
    The New England journal of medicine
  • 1984
A large number of the questioned patients believe that the use of quantitative methods to guide the allocation of health-care resources should be considered as a waste of time and money.

The economics of treating chronic renal failure

Some of the economic aspects of treating chronic renal failure are considered, particularly the level of finance available.

An Introduction to Cost-Effectiveness Analysis

This chapter outlines the principles of cost-effectiveness analysis, and compares different types of Cost-Effectiveness analysis to evaluate whether the effect of a healthcare intervention justifies additional expenditure.

Health Economic Evaluations: The Special Case of End-Stage Renal Disease Treatment

Use of the cost-effectiveness ratio of $55,000/LY for center hemodialysis as a lower boundary of society’s willingness to pay for an additional life-year can be supported under certain assumptions.

The cost of urogynaecological treatments: Which are more cost‐effective?

  • A. FooteK. H. Moore
  • Medicine, Chemistry
    The Australian & New Zealand journal of obstetrics & gynaecology
  • 2007
To determine the cost‐effectiveness of four urogynaecological treatments, a large number of patients are randomly assigned to one of four experimental groups for each of the four treatments.

Economic evaluation of dialysis therapies

Variations in the intrinsic costs of the available dialysis modalities as well as other factors, such as variation by country, available health-care infrastructures, the timing of dialysis initiation and renal transplantation are discussed.